Evaluating efficacy of a Unani formulation in melasma.
Phase 2
- Conditions
- Health Condition 1: L811- Chloasma
- Registration Number
- CTRI/2021/09/036582
- Lead Sponsor
- ational Research institute of Unani medicine for skin disorders
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participant having single or multiple, symmetrical
or asymmetrical brown macules on face, cheeks, nose, forehead, upper lip and chin.
Exclusion Criteria
a) Women who are pregnant, and lactating.
b) Participant aged <18 years or >55 years.
c) Significant cardiovascular/ pulmonary/ hepatorenal dysfunction.
d) Known case of diabetes mellitus, HIV/ AIDS and malignancy.
e) Those unwilling to come for regular follow-up for the entire duration of the study and any patients considered not eligible according to the investigatorâ??s discretion during the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 25% reduction in MASI score from the baseline after 8 weeks of treatment.Timepoint: 8 Weeks
- Secondary Outcome Measures
Name Time Method improvement in quality of life.Timepoint: 8 weeks